Tirzepatide (Mounjaro / Zepbound): A newer medication that has shown promising results in both managing blood sugar and promoting weight loss
More importantly, the tumor-promoting effect of insulin in pancreatic cancer cells and the TME is essential, which makes insulin and its related signal pathway a potential novel target for cancer therapies
Most plans require a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or sleep apnea
Reduced Glutathione is the body's master antioxidant, protecting cells from oxidative damage caused by free radicals, pollution, UV exposure, and metabolic stress
The Plovanich data (2015, replicated since)
How much weight someone loses influences continuation decisions